
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVACs product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, and mumps. The COVID-19 vaccine, CoronaVac, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive, is an innovative vaccine under Category 1 Preventative Biological Products and was commercialized in China in 2016. In 2022, SINOVACs...
Influenza vaccines,inactivated hepatitis a vaccine,ev71 vaccine,and vaccine
Sinovac biotech ltd operates in the Biotechnology research industry.
Sinovac biotech ltd's revenue is 101m - 500m
Sinovac biotech ltd has 201 - 500 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.